Coenzyme studied in cellular energy-metabolism and sirtuin-pathway models.
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
NAD+/NADH redox reactions and cellular energy metabolism; substrate roles in sirtuin and PARP pathways associated with cellular maintenance and DNA-damage responses. A small intravenous study measured metabolism, not clinical rejuvenation, cognitive improvement or fatigue relief.
The physiological role of NAD+ is not proof that administering NAD+ produces the same benefits. Oral precursor and intravenous studies do not validate the Avitus pen, its absorption or clinical effects.
PMID: 31572171
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.